Search
News
Important Only
Stocks
Bernstein downgrades Target stock ahead of Q1 print on near-term headwinds
Investing.com -- Bernstein downgraded Target stock to Underperform from Market-Perform, pointing out a combination of near-term headwinds and structural challenges that threaten its longer-term grInvesting.com
May 12, 2025
Stocks
KindlyMD soars on deal with David Bailey-backed Nakamoto to launch bitcoin treasury
** Healthcare firm KindlyMD's KDLY.O shares rocket 438.5% to $21 premarket** KDLY agrees to merge with Nakamoto Holdings, founded by crypto entrepreneur David Bailey, to start bitcoin treasury strategy** Firm is latest in growing cohort of companies that have attempted to replicate approach of M...Reuters
May 12, 2025
Forex
David Bailey And Bitcoin-Native Holding Company Nakamoto Announce Merger With Kindlymd To Establish Bitcoin Treasury
May 12 (Reuters) - Kindly MD Inc KDLY.O:DAVID BAILEY AND BITCOIN-NATIVE HOLDING COMPANY NAKAMOTO ANNOUNCE MERGER WITH KINDLYMD® TO ESTABLISH BITCOIN TREASURYDAVID BAILEY AND BITCOIN-NATIVE HOLDING COMPANY NAKAMOTO ANNOUNCE MERGER WITH KINDLYMD® TO ESTABLISH BITCOIN TREASURYKINDLY MD - DEAL INCLUDES ...Reuters
May 12, 2025
Other
Li-Cycle Receives Further Waiver Extensions From Convertible Note Holders
May 12 (Reuters) - Li-Cycle Holdings Corp LICYN.MX:LI-CYCLE RECEIVES FURTHER WAIVER EXTENSIONS FROM CONVERTIBLE NOTE HOLDERSLI-CYCLE: CONSIDERING CO'S CURRENT CIRCUMSTANCES, WILL NEED TO SIGNIFICANTLY MODIFY OR TERMINATE ITS OPERATIONSReuters
May 12, 2025
Other
Dentalcorp Q1 Adjusted EBITDA CAD 75.9 Million
May 12 (Reuters) - dentalcorp Holdings Ltd DNTL.TO:DENTALCORP Q1 ADJUSTED EBITDA CAD 75.9 MILLIONDENTALCORP Q1 ADJUSTED NET INCOME CAD 20.7 MILLIONDENTALCORP Q1 REVENUE CAD 409.4 MILLION VERSUS. IBES ESTIMATE CAD 404.6 MILLIONDENTALCORP Q1 ADJUSTED EBITDA MARGIN 18.5%Reuters
May 12, 2025
Cryptocurrencies
XRP Price Surge To $10: Analyst Reveals Factors That Will Make It Happen In 2025
Following the XRP price’s stellar performance in the current bull cycle, a crypto analyst has now predicted that the value of the third-largest cryptocurrency could soon soar to $10 or more in 2025. This bullish projection is backed by several key factors expected to drive strong demand and bo...NewsBTC
May 12, 2025
Stocks
Is it Too Late to Buy The Trade Desk Stock?
The Trade Desk (NASDAQ: TTD) delivered excellent quarterly financial results that sent the stock price soaring. Stock market investors are curious if it is too late to buy after the increase.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to ...The Motley Fool
May 12, 2025
Stocks
Better Dividend Stock: Occidental Petroleum vs. Energy Transfer
Occidental Petroleum (NYSE: OXY) and Energy Transfer (NYSE: ET) are popular income stocks for energy-focused investors. Occidental, also known as Oxy, is a leading oil and gas producer. Energy Transfer is a major midstream pipeline operator.Occidental pays a forward yield of 2.4%. It cut its dividen...The Motley Fool
May 12, 2025
Commodities
RPT-COLUMN-Funds might be short CBOT corn heading into Monday's data dump: Braun
By Karen Braun NAPERVILLE, Illinois, May 11 (Reuters) - When it comes to Chicago corn futures, speculators typically hold on to heavily bullish corn bets for an extended period. Ditching them after just a few months is unusual.But investors might be bearish heading into Monday’s reports from the ...Reuters
May 12, 2025
Other
Advantage Solutions Reports First Quarter 2025 Results
May 12 (Reuters) - Advantage Solutions Inc ADV.O:ADVANTAGE SOLUTIONS REPORTS FIRST QUARTER 2025 RESULTSADVANTAGE SOLUTIONS INC OUTLOOK FY25 REVENUE DOWN LOW SINGLE DIGITS TO FLATADVANTAGE SOLUTIONS INC QTRLY REVENUES DECLINED 5% TO $822 MILLIONADVANTAGE SOLUTIONS INC: UPDATED FY GUIDANCE REFLECTS NE...Reuters
May 12, 2025
Other
Alnylam To Share Progress Across Its Transthyretin Amyloidosis Franchise Including Additional Analyses Of The Helios-B Phase 3 Study Results At Heart Failure 2025 Congress
May 12 (Reuters) - Alnylam Pharmaceuticals Inc ALNY.O:ALNYLAM TO SHARE PROGRESS ACROSS ITS TRANSTHYRETIN AMYLOIDOSIS FRANCHISE INCLUDING ADDITIONAL ANALYSES OF THE HELIOS-B PHASE 3 STUDY RESULTS AT HEART FAILURE 2025 CONGRESSReuters
May 12, 2025
Other
Precore Gold Announces Nomination Of Louis Gariepy To Its Board Of Directors, Completion Of The Arikepay Agreement And Granting Of Stock Options
May 12 (Reuters) - Precore Gold Corp PRCG.CD:PRECORE GOLD ANNOUNCES NOMINATION OF LOUIS GARIEPY TO ITS BOARD OF DIRECTORS, COMPLETION OF THE ARIKEPAY AGREEMENT AND GRANTING OF STOCK OPTIONSReuters
May 12, 2025
Other
Amylyx Pharmaceuticals Announces Positive Long-Term Results From Phase 2 Helios Clinical Trial Of Amx0035 In People With Wolfram Syndrome
May 12 (Reuters) - Amylyx Pharmaceuticals Inc AMLX.O:AMYLYX PHARMACEUTICALS ANNOUNCES POSITIVE LONG-TERM RESULTS FROM PHASE 2 HELIOS CLINICAL TRIAL OF AMX0035 IN PEOPLE WITH WOLFRAM SYNDROMEAMYLYX PHARMACEUTICALS INC - AMX0035 WELL-TOLERATED IN ALL PARTICIPANTSAMYLYX PHARMACEUTICALS INC - EXPECTS CA...Reuters
May 12, 2025
Stocks
US STOCKS-Wall St stock futures soar as US, China slash tariffs
Futures advance: Dow 2.38%, S&P 500 3%, Nasdaq 3.93%US, China reach deal to cut tariffsU.S. drugmakers fall as Trump to cut drug pricesBy Shashwat Chauhan and Pranav Kashyap May 12 (Reuters) - U.S. stock index futures jumped on Monday after the United States and China reached a deal to reduce...Reuters
May 12, 2025
Forex
Brazil's Lula criticizes U.S. tariffs while reaffirming partnership with China
SAO PAULO, May 12 (Reuters) - Brazilian President Luiz Inacio Lula da Silva on Monday showed his dissatisfaction with U.S. tariffs and said Brazil is seeking to strengthen ties with China. "Amid the resurgence of protectionist barriers, we are committed to reducing industrial barriers and want m...Reuters
May 12, 2025
Other
Cytomx Therapeutics Q1 Net Income USD 23.525 Million
May 12 (Reuters) - CytomX Therapeutics Inc CTMX.O:CYTOMX THERAPEUTICS Q1 NET INCOME USD 23.525 MILLIONCYTOMX THERAPEUTICS Q1 OPERATING EXPENSES USD 28.296 MILLIONCYTOMX THERAPEUTICS Q1 OPERATING INCOME USD 22.621 MILLIONCYTOMX THERAPEUTICS Q1 REVENUE USD 50.917 MILLIONCYTOMX THERAPEUTICS Q1 CASH &am...Reuters
May 12, 2025
Featured Tools
Top News
Micron Technology Stock Outlook: Can MU Stock Rally Above $1,000 in 2026?
SpaceX IPO Date Moved Up to June 12: What Should Investors Watch? How Can European and Asian Investors Buy SpaceX Shares? What Is the Impact on Broad US Markets?
Nvidia Reports Q1 FY2027 Earnings on May 20 - Is NVDA a Buy at $224 Before the Most Important Print of the Year?
SpaceX IPO Date Set for June 12 at a $1.75 Trillion Valuation - Everything You Need to Know About SPCX
OpenAI Restructuring: Merging ChatGPT & Codex for AI Agents to Fight $900B Anthropic Ahead of IPO
